nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—GRK7—eye—leprosy	0.0126	0.0295	CbGeAlD
Ruxolitinib—CAMK2G—nerve—leprosy	0.00983	0.023	CbGeAlD
Ruxolitinib—MAP3K3—peripheral nervous system—leprosy	0.00977	0.0229	CbGeAlD
Ruxolitinib—LRRK2—nerve—leprosy	0.00975	0.0228	CbGeAlD
Ruxolitinib—GRK1—eye—leprosy	0.00912	0.0213	CbGeAlD
Ruxolitinib—BMPR2—blood vessel—leprosy	0.00863	0.0202	CbGeAlD
Ruxolitinib—PLK1—skin of body—leprosy	0.00746	0.0175	CbGeAlD
Ruxolitinib—PLK1—Menadione—Thalidomide—leprosy	0.00734	0.5	CbGdCrCtD
Ruxolitinib—PLK4—Menadione—Thalidomide—leprosy	0.00734	0.5	CbGdCrCtD
Ruxolitinib—ANKK1—testis—leprosy	0.00633	0.0148	CbGeAlD
Ruxolitinib—ANKK1—nervous system—leprosy	0.00621	0.0145	CbGeAlD
Ruxolitinib—JAK2—blood vessel—leprosy	0.00621	0.0145	CbGeAlD
Ruxolitinib—PRKCE—tendon—leprosy	0.00591	0.0138	CbGeAlD
Ruxolitinib—RPS6KA6—tendon—leprosy	0.00568	0.0133	CbGeAlD
Ruxolitinib—CAMK1D—eye—leprosy	0.00536	0.0125	CbGeAlD
Ruxolitinib—PRKG2—testis—leprosy	0.00524	0.0123	CbGeAlD
Ruxolitinib—PRKG2—nervous system—leprosy	0.00514	0.012	CbGeAlD
Ruxolitinib—GRK1—nervous system—leprosy	0.00491	0.0115	CbGeAlD
Ruxolitinib—PRKCE—testis—leprosy	0.00489	0.0114	CbGeAlD
Ruxolitinib—PRKCE—nervous system—leprosy	0.0048	0.0112	CbGeAlD
Ruxolitinib—JAK1—skin of body—leprosy	0.00478	0.0112	CbGeAlD
Ruxolitinib—ROCK1—eye—leprosy	0.00473	0.0111	CbGeAlD
Ruxolitinib—PLK1—testis—leprosy	0.0047	0.011	CbGeAlD
Ruxolitinib—RPS6KA6—testis—leprosy	0.0047	0.011	CbGeAlD
Ruxolitinib—MAST1—testis—leprosy	0.0047	0.011	CbGeAlD
Ruxolitinib—PLK1—nervous system—leprosy	0.00461	0.0108	CbGeAlD
Ruxolitinib—MAST1—nervous system—leprosy	0.00461	0.0108	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—leprosy	0.00461	0.0108	CbGeAlD
Ruxolitinib—DCLK3—testis—leprosy	0.00446	0.0104	CbGeAlD
Ruxolitinib—CAMK1—tendon—leprosy	0.00443	0.0104	CbGeAlD
Ruxolitinib—DCLK3—nervous system—leprosy	0.00437	0.0102	CbGeAlD
Ruxolitinib—MARK2—tendon—leprosy	0.0043	0.0101	CbGeAlD
Ruxolitinib—CAMK2G—eye—leprosy	0.00411	0.00961	CbGeAlD
Ruxolitinib—BMPR2—skin of body—leprosy	0.004	0.00935	CbGeAlD
Ruxolitinib—TAOK2—tendon—leprosy	0.00398	0.00931	CbGeAlD
Ruxolitinib—PLK3—testis—leprosy	0.00392	0.00918	CbGeAlD
Ruxolitinib—PLK3—nervous system—leprosy	0.00385	0.00901	CbGeAlD
Ruxolitinib—LTK—testis—leprosy	0.00379	0.00887	CbGeAlD
Ruxolitinib—CAMK1—testis—leprosy	0.00367	0.00859	CbGeAlD
Ruxolitinib—JAK1—tendon—leprosy	0.00364	0.00851	CbGeAlD
Ruxolitinib—DCLK1—tendon—leprosy	0.00364	0.00851	CbGeAlD
Ruxolitinib—TYK2—eye—leprosy	0.00363	0.00849	CbGeAlD
Ruxolitinib—CAMK1—nervous system—leprosy	0.0036	0.00843	CbGeAlD
Ruxolitinib—MKNK2—eye—leprosy	0.00358	0.00838	CbGeAlD
Ruxolitinib—MARK2—testis—leprosy	0.00356	0.00834	CbGeAlD
Ruxolitinib—CAMK1D—tendon—leprosy	0.00355	0.0083	CbGeAlD
Ruxolitinib—PHKG2—tendon—leprosy	0.00353	0.00825	CbGeAlD
Ruxolitinib—MARK2—nervous system—leprosy	0.0035	0.00818	CbGeAlD
Ruxolitinib—DAPK2—tendon—leprosy	0.00347	0.00811	CbGeAlD
Ruxolitinib—STK16—tendon—leprosy	0.00341	0.00798	CbGeAlD
Ruxolitinib—HIPK2—tendon—leprosy	0.00339	0.00794	CbGeAlD
Ruxolitinib—TAOK2—testis—leprosy	0.0033	0.00771	CbGeAlD
Ruxolitinib—DAPK3—tendon—leprosy	0.00326	0.00763	CbGeAlD
Ruxolitinib—CLK2—tendon—leprosy	0.00323	0.00756	CbGeAlD
Ruxolitinib—TYK2—skin of body—leprosy	0.00316	0.00739	CbGeAlD
Ruxolitinib—BMPR2—tendon—leprosy	0.00304	0.00712	CbGeAlD
Ruxolitinib—JAK3—testis—leprosy	0.00303	0.00709	CbGeAlD
Ruxolitinib—JAK1—testis—leprosy	0.00301	0.00704	CbGeAlD
Ruxolitinib—DCLK1—testis—leprosy	0.00301	0.00704	CbGeAlD
Ruxolitinib—PLK4—testis—leprosy	0.00299	0.007	CbGeAlD
Ruxolitinib—JAK3—nervous system—leprosy	0.00297	0.00696	CbGeAlD
Ruxolitinib—JAK1—nervous system—leprosy	0.00295	0.00691	CbGeAlD
Ruxolitinib—DCLK1—nervous system—leprosy	0.00295	0.00691	CbGeAlD
Ruxolitinib—CAMK1D—testis—leprosy	0.00294	0.00687	CbGeAlD
Ruxolitinib—PHKG2—testis—leprosy	0.00292	0.00683	CbGeAlD
Ruxolitinib—TAOK3—eye—leprosy	0.0029	0.00679	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—leprosy	0.00288	0.00675	CbGeAlD
Ruxolitinib—JAK2—skin of body—leprosy	0.00287	0.00672	CbGeAlD
Ruxolitinib—DAPK2—testis—leprosy	0.00287	0.00672	CbGeAlD
Ruxolitinib—PHKG2—nervous system—leprosy	0.00287	0.00671	CbGeAlD
Ruxolitinib—STK16—testis—leprosy	0.00283	0.00661	CbGeAlD
Ruxolitinib—HIPK2—testis—leprosy	0.00281	0.00658	CbGeAlD
Ruxolitinib—STK16—nervous system—leprosy	0.00277	0.00649	CbGeAlD
Ruxolitinib—MAP3K3—skin of body—leprosy	0.00277	0.00648	CbGeAlD
Ruxolitinib—HIPK2—nervous system—leprosy	0.00276	0.00645	CbGeAlD
Ruxolitinib—MAP3K19—testis—leprosy	0.00275	0.00644	CbGeAlD
Ruxolitinib—CAMK2G—tendon—leprosy	0.00272	0.00637	CbGeAlD
Ruxolitinib—BMP2K—tendon—leprosy	0.00272	0.00637	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—leprosy	0.0027	0.00632	CbGeAlD
Ruxolitinib—DAPK3—testis—leprosy	0.0027	0.00632	CbGeAlD
Ruxolitinib—LRRK2—tendon—leprosy	0.0027	0.00631	CbGeAlD
Ruxolitinib—CLK2—testis—leprosy	0.00268	0.00626	CbGeAlD
Ruxolitinib—DAPK3—nervous system—leprosy	0.00265	0.0062	CbGeAlD
Ruxolitinib—CLK2—nervous system—leprosy	0.00263	0.00614	CbGeAlD
Ruxolitinib—ROCK1—testis—leprosy	0.00259	0.00607	CbGeAlD
Ruxolitinib—ROCK1—nervous system—leprosy	0.00254	0.00595	CbGeAlD
Ruxolitinib—DYRK1A—testis—leprosy	0.00253	0.00592	CbGeAlD
Ruxolitinib—BMPR2—testis—leprosy	0.00252	0.00589	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—leprosy	0.00248	0.00581	CbGeAlD
Ruxolitinib—BMPR2—nervous system—leprosy	0.00247	0.00578	CbGeAlD
Ruxolitinib—MAP3K7—tendon—leprosy	0.00245	0.00573	CbGeAlD
Ruxolitinib—NUAK2—testis—leprosy	0.00241	0.00563	CbGeAlD
Ruxolitinib—TYK2—tendon—leprosy	0.0024	0.00562	CbGeAlD
Ruxolitinib—MKNK2—tendon—leprosy	0.00237	0.00555	CbGeAlD
Ruxolitinib—IRAK1—tendon—leprosy	0.00237	0.00555	CbGeAlD
Ruxolitinib—RET—tendon—leprosy	0.00231	0.00541	CbGeAlD
Ruxolitinib—CAMK2G—testis—leprosy	0.00225	0.00527	CbGeAlD
Ruxolitinib—BMP2K—testis—leprosy	0.00225	0.00527	CbGeAlD
Ruxolitinib—LRRK2—testis—leprosy	0.00223	0.00523	CbGeAlD
Ruxolitinib—BMP2K—nervous system—leprosy	0.00221	0.00517	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—leprosy	0.00221	0.00517	CbGeAlD
Ruxolitinib—LRRK2—nervous system—leprosy	0.00219	0.00513	CbGeAlD
Ruxolitinib—JAK2—tendon—leprosy	0.00219	0.00512	CbGeAlD
Ruxolitinib—MAP3K3—tendon—leprosy	0.00211	0.00493	CbGeAlD
Ruxolitinib—MAP3K2—testis—leprosy	0.00205	0.00479	CbGeAlD
Ruxolitinib—MAP3K7—testis—leprosy	0.00203	0.00474	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—leprosy	0.00201	0.0047	CbGeAlD
Ruxolitinib—TYK2—testis—leprosy	0.00199	0.00466	CbGeAlD
Ruxolitinib—MKNK2—testis—leprosy	0.00196	0.0046	CbGeAlD
Ruxolitinib—IRAK1—testis—leprosy	0.00196	0.0046	CbGeAlD
Ruxolitinib—TYK2—nervous system—leprosy	0.00195	0.00457	CbGeAlD
Ruxolitinib—MKNK2—nervous system—leprosy	0.00193	0.00451	CbGeAlD
Ruxolitinib—TAOK3—tendon—leprosy	0.00192	0.0045	CbGeAlD
Ruxolitinib—RET—testis—leprosy	0.00192	0.00448	CbGeAlD
Ruxolitinib—RET—nervous system—leprosy	0.00188	0.0044	CbGeAlD
Ruxolitinib—JAK2—testis—leprosy	0.00181	0.00424	CbGeAlD
Ruxolitinib—JAK2—nervous system—leprosy	0.00178	0.00416	CbGeAlD
Ruxolitinib—MAP3K3—testis—leprosy	0.00175	0.00408	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—leprosy	0.00171	0.00401	CbGeAlD
Ruxolitinib—TAOK3—testis—leprosy	0.00159	0.00372	CbGeAlD
Ruxolitinib—TAOK3—nervous system—leprosy	0.00156	0.00365	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—leprosy	0.000475	0.00111	CbGeAlD
Ruxolitinib—JAK2—Interferon gamma signaling—IFNG—leprosy	0.000453	0.000812	CbGpPWpGaD
Ruxolitinib—MAP3K7—TCR Signaling Pathway—CD4—leprosy	0.000453	0.000811	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—RIPK2—leprosy	0.000452	0.000811	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—TLR2—leprosy	0.000452	0.000811	CbGpPWpGaD
Ruxolitinib—PLK1—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000452	0.000811	CbGpPWpGaD
Ruxolitinib—JAK2—IL12-mediated signaling events—IL2—leprosy	0.00045	0.000807	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cardiac Hypertrophic Response—TNF—leprosy	0.00045	0.000806	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000445	0.000798	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000445	0.000798	CbGpPWpGaD
Ruxolitinib—ROCK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.00044	0.000789	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—RIPK2—leprosy	0.000438	0.000785	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000432	0.000775	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—RIPK2—leprosy	0.000425	0.000762	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.00042	0.000753	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000419	0.000752	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—NOD2—leprosy	0.00041	0.000735	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CYLD—leprosy	0.000409	0.000733	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—NOD2—leprosy	0.000404	0.000724	CbGpPWpGaD
Ruxolitinib—TYK2—Interferon Signaling—HLA-DRB1—leprosy	0.0004	0.000716	CbGpPWpGaD
Ruxolitinib—JAK1—Interferon Signaling—IFNG—leprosy	0.000395	0.000709	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—NOD2—leprosy	0.000392	0.000703	CbGpPWpGaD
Ruxolitinib—PRKCE—Platelet activation, signaling and aggregation—IL2—leprosy	0.00039	0.0007	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CYLD—leprosy	0.000388	0.000695	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by Interleukins—IL2—leprosy	0.000382	0.000685	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—NOD2—leprosy	0.00038	0.000681	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CYLD—leprosy	0.000376	0.000674	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CYLD—leprosy	0.000374	0.000671	CbGpPWpGaD
Ruxolitinib—JAK2—CXCR4-mediated signaling events—CD4—leprosy	0.000374	0.00067	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by Interleukins—IL2—leprosy	0.000371	0.000665	CbGpPWpGaD
Ruxolitinib—MAP3K2—MAPK Signaling Pathway—TNF—leprosy	0.000368	0.00066	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CYLD—leprosy	0.000366	0.000656	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CYLD—leprosy	0.000365	0.000654	CbGpPWpGaD
Ruxolitinib—PRKG2—Hemostasis—IL2—leprosy	0.000364	0.000653	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PARK2—leprosy	0.000361	0.000648	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000361	0.000648	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling by Interleukins—IL2—leprosy	0.00036	0.000645	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.000351	0.000629	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CYLD—leprosy	0.000345	0.000618	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—SLC11A1—leprosy	0.000334	0.000598	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—IFNG—leprosy	0.000333	0.000597	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PARK2—leprosy	0.000331	0.000593	CbGpPWpGaD
Ruxolitinib—JAK3—Platelet activation, signaling and aggregation—IL2—leprosy	0.000329	0.000591	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—RIPK2—leprosy	0.000328	0.000589	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—TLR2—leprosy	0.000328	0.000589	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—RIPK2—leprosy	0.000328	0.000587	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—IFNG—leprosy	0.000325	0.000583	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PARK2—leprosy	0.000323	0.00058	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—RIPK2—leprosy	0.000322	0.000577	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—PARK2—leprosy	0.00031	0.000555	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—RIPK2—leprosy	0.000309	0.000553	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—IFNG—leprosy	0.000307	0.00055	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PARK2—leprosy	0.000305	0.000547	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—HLA-DRB1—leprosy	0.000303	0.000543	CbGpPWpGaD
Ruxolitinib—MAP3K7—TNF alpha Signaling Pathway—TNF—leprosy	0.000298	0.000534	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—NOD2—leprosy	0.000298	0.000534	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—NOD2—leprosy	0.000297	0.000532	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CYLD—leprosy	0.000297	0.000532	CbGpPWpGaD
Ruxolitinib—CAMK2G—Cytokine Signaling in Immune system—IL2—leprosy	0.000296	0.00053	CbGpPWpGaD
Ruxolitinib—TYK2—Interferon Signaling—IFNG—leprosy	0.000292	0.000523	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000291	0.000522	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—RIPK2—leprosy	0.00029	0.00052	CbGpPWpGaD
Ruxolitinib—MAP3K3—Cytokine Signaling in Immune system—IL2—leprosy	0.000289	0.000518	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CYLD—leprosy	0.000285	0.000511	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—IL2—leprosy	0.000283	0.000508	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Interleukins—IL2—leprosy	0.000281	0.000504	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000275	0.000493	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-like Receptor Signaling Pathway—TNF—leprosy	0.000274	0.000492	CbGpPWpGaD
Ruxolitinib—JAK3—Cytokine Signaling in Immune system—IL2—leprosy	0.000273	0.000489	CbGpPWpGaD
Ruxolitinib—ROCK1—Apoptosis—TNF—leprosy	0.00027	0.000483	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000267	0.000478	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—IFNG—leprosy	0.000264	0.000473	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—RIPK2—leprosy	0.000263	0.000472	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—TLR2—leprosy	0.000263	0.000472	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PARK2—leprosy	0.000262	0.00047	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—RIPK2—leprosy	0.000262	0.00047	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—TNF—leprosy	0.000262	0.00047	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000259	0.000464	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—RIPK2—leprosy	0.00025	0.000448	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—TLR2—leprosy	0.00025	0.000448	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—RIPK2—leprosy	0.000242	0.000435	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—TLR2—leprosy	0.000242	0.000435	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—SLC11A1—leprosy	0.000242	0.000434	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—TLR2—leprosy	0.000241	0.000433	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—RIPK2—leprosy	0.000241	0.000433	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—NOD2—leprosy	0.000239	0.000428	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—RIPK2—leprosy	0.000236	0.000423	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—TLR2—leprosy	0.000236	0.000423	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—RIPK2—leprosy	0.000235	0.000422	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—TLR2—leprosy	0.000235	0.000422	CbGpPWpGaD
Ruxolitinib—JAK1—Cytokine Signaling in Immune system—IL2—leprosy	0.000235	0.00042	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000227	0.000408	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—NOD2—leprosy	0.000226	0.000406	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—RIPK2—leprosy	0.000226	0.000405	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CYLD—leprosy	0.000226	0.000405	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—TLR2—leprosy	0.000222	0.000399	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—RIPK2—leprosy	0.000222	0.000399	CbGpPWpGaD
Ruxolitinib—JAK2—Interferon Signaling—IFNG—leprosy	0.000221	0.000396	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—NOD2—leprosy	0.00022	0.000394	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CYLD—leprosy	0.000219	0.000393	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—NOD2—leprosy	0.000219	0.000392	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—leprosy	0.000214	0.000384	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NOD2—leprosy	0.000214	0.000383	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—NOD2—leprosy	0.000213	0.000382	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CYLD—leprosy	0.000213	0.000381	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	0.000202	0.000362	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD40LG—leprosy	0.000202	0.000362	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NOD2—leprosy	0.000202	0.000361	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—IL2—leprosy	0.000201	0.000361	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IFNG—leprosy	0.000201	0.00036	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD8A—leprosy	0.0002	0.000358	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PARK2—leprosy	0.0002	0.000358	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—CD4—leprosy	0.000197	0.000353	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IFNG—leprosy	0.000195	0.000349	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PARK2—leprosy	0.000194	0.000347	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—RIPK2—leprosy	0.000191	0.000343	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—TLR2—leprosy	0.000191	0.000343	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IFNG—leprosy	0.000189	0.000339	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PARK2—leprosy	0.000188	0.000337	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD40LG—leprosy	0.000185	0.000332	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TNF—leprosy	0.000184	0.00033	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—RIPK2—leprosy	0.000184	0.000329	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—TLR2—leprosy	0.000184	0.000329	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD8A—leprosy	0.000183	0.000328	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD40LG—leprosy	0.000181	0.000324	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—CD4—leprosy	0.00018	0.000323	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SLC11A1—leprosy	0.000179	0.000321	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD8A—leprosy	0.000179	0.00032	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—IL2—leprosy	0.000178	0.00032	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NOD2—leprosy	0.000173	0.000311	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—IL2—leprosy	0.000173	0.00031	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD40LG—leprosy	0.000173	0.00031	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD8A—leprosy	0.000171	0.000307	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD40LG—leprosy	0.00017	0.000305	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—RIPK2—leprosy	0.00017	0.000305	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—IL2—leprosy	0.00017	0.000304	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD8A—leprosy	0.000168	0.000302	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—IL2—leprosy	0.000168	0.000301	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NOD2—leprosy	0.000167	0.000299	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CYLD—leprosy	0.000166	0.000298	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—CD4—leprosy	0.000163	0.000292	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—HLA-DRB1—leprosy	0.000163	0.000291	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—IL2—leprosy	0.000159	0.000284	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—HLA-DRB1—leprosy	0.000149	0.000267	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IFNG—leprosy	0.000148	0.000265	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PARK2—leprosy	0.000147	0.000263	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD40LG—leprosy	0.000147	0.000263	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—IL2—leprosy	0.000146	0.000262	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—HLA-DRB1—leprosy	0.000145	0.000261	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—RIPK2—leprosy	0.000145	0.000261	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—TLR2—leprosy	0.000145	0.000261	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD8A—leprosy	0.000145	0.00026	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—RIPK2—leprosy	0.000144	0.000258	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—CD4—leprosy	0.000143	0.000256	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—RIPK2—leprosy	0.000141	0.000253	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—TLR2—leprosy	0.000141	0.000253	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HLA-DRB1—leprosy	0.000139	0.00025	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HLA-DRB1—leprosy	0.000137	0.000246	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—RIPK2—leprosy	0.000137	0.000245	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TLR2—leprosy	0.000137	0.000245	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SLC11A1—leprosy	0.000136	0.000243	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NOD2—leprosy	0.000132	0.000236	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL2—leprosy	0.000131	0.000235	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NOD2—leprosy	0.000128	0.000229	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—IL2—leprosy	0.000127	0.000228	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NOD2—leprosy	0.000124	0.000223	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RIPK2—leprosy	0.000124	0.000222	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL2—leprosy	0.000124	0.000222	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RIPK2—leprosy	0.000122	0.000218	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IFNG—leprosy	0.000119	0.000213	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HLA-DRB1—leprosy	0.000118	0.000212	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL2—leprosy	0.000116	0.000208	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL2—leprosy	0.000115	0.000207	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—CD4—leprosy	0.000115	0.000206	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD40LG—leprosy	0.000111	0.0002	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD8A—leprosy	0.00011	0.000198	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IFNG—leprosy	0.000109	0.000195	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—CD4—leprosy	0.000109	0.000195	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—leprosy	0.000108	0.000194	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD40LG—leprosy	0.000108	0.000194	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—IL2—leprosy	0.000107	0.000192	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—RIPK2—leprosy	0.000107	0.000192	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR2—leprosy	0.000107	0.000192	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD8A—leprosy	0.000107	0.000192	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—leprosy	0.000107	0.000191	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IFNG—leprosy	0.000106	0.00019	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—CD4—leprosy	0.000106	0.00019	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—CD4—leprosy	0.000106	0.000189	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL2—leprosy	0.000106	0.000189	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL2—leprosy	0.000105	0.000188	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—CD4—leprosy	0.000105	0.000188	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD40LG—leprosy	0.000105	0.000188	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD8A—leprosy	0.000104	0.000186	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CD4—leprosy	0.000103	0.000184	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—CD4—leprosy	0.000102	0.000183	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IFNG—leprosy	0.0001	0.00018	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CD4—leprosy	9.83e-05	0.000176	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL2—leprosy	9.75e-05	0.000175	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NOD2—leprosy	9.7e-05	0.000174	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CD4—leprosy	9.68e-05	0.000173	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL2—leprosy	9.66e-05	0.000173	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL2—leprosy	9.44e-05	0.000169	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RIPK2—leprosy	9.4e-05	0.000169	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—IL2—leprosy	9.23e-05	0.000165	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RIPK2—leprosy	9.13e-05	0.000164	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—IL2—leprosy	9.08e-05	0.000163	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HLA-DRB1—leprosy	8.98e-05	0.000161	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL2—leprosy	8.9e-05	0.00016	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RIPK2—leprosy	8.85e-05	0.000159	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-DRB1—leprosy	8.71e-05	0.000156	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IFNG—leprosy	8.62e-05	0.000155	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-DRB1—leprosy	8.45e-05	0.000152	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL2—leprosy	8.38e-05	0.00015	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—leprosy	8.33e-05	0.000149	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL2—leprosy	8.25e-05	0.000148	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD40LG—leprosy	8.2e-05	0.000147	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—leprosy	8.17e-05	0.000147	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD8A—leprosy	8.11e-05	0.000145	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—leprosy	8.01e-05	0.000144	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—leprosy	8e-05	0.000143	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—leprosy	7.69e-05	0.000138	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—leprosy	7.66e-05	0.000137	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RIPK2—leprosy	6.92e-05	0.000124	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—leprosy	6.82e-05	0.000122	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—leprosy	6.6e-05	0.000118	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—leprosy	6.56e-05	0.000118	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—leprosy	6.36e-05	0.000114	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—leprosy	6.33e-05	0.000113	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—leprosy	6.19e-05	0.000111	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—leprosy	6.17e-05	0.000111	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—leprosy	6.15e-05	0.00011	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—leprosy	6.07e-05	0.000109	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—leprosy	5.96e-05	0.000107	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—leprosy	5.83e-05	0.000104	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—leprosy	5.76e-05	0.000103	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—leprosy	5.67e-05	0.000102	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—leprosy	5.66e-05	0.000101	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—leprosy	5.48e-05	9.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—leprosy	5.17e-05	9.26e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—leprosy	4.95e-05	8.88e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—leprosy	4.87e-05	8.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—leprosy	4.82e-05	8.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—leprosy	4.69e-05	8.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—leprosy	4.66e-05	8.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—leprosy	4.3e-05	7.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—leprosy	4.29e-05	7.68e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SDHD—leprosy	4.27e-05	7.65e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—leprosy	3.77e-05	6.75e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—leprosy	3.66e-05	6.55e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—leprosy	3.55e-05	6.36e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—leprosy	2.77e-05	4.97e-05	CbGpPWpGaD
